Clinical Trial Update: Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the addition of metformin to abiraterone in metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• metformin (metformin)

Snippet

Sponsor: Kantonsspital Graubünden | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: COMPLETED